A man’s height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say British researchers who conducted their own study on the connection and also reviewed 58 published studies.
In the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, 12 British researchers at four universities in England studied more than 9,000 men with and without prostate cancer and estimated that the risk of developing the disease rises by about six percent for every 10 centimeters (3.9 inches) in height a man is over the shortest group of men in the study.
According to researchers who conducted their own study on the connection and also reviewed 58 published studies, the man’s height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer. That means a man who is one foot taller than the shortest person in the study would have a 19 percent increased risk of developing the disease.
Still, these increases in risk are a lot less than those linked with other established risk factors, such as age, family history of the disease, and race. Because of that, the researchers do not suggest that taller men be screened more often than is typical, or that their cancer treatment be altered.
No User Responded In This Post
Leave Your Comments Here...